Based on the Sandoz Group AG stock forecast from 0 analysts, the average analyst target price for Sandoz Group AG is not available over the next 12 months. Sandoz Group AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Sandoz Group AG is Slightly Bullish , which is based on 6 positive signals and 3 negative signals. At the last closing, Sandoz Group AG’s stock price was CHF 37.14. Sandoz Group AG’s stock price has changed by +0.19% over the past week, -6.85% over the past month and +36.59% over the last year.
No recent analyst target price found for Sandoz Group AG
No recent average analyst rating found for Sandoz Group AG
Company Overview Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. Address: Forum 1, Basel, Switzerland, 4056 Read Less
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology,...Read More
Frequently Asked Questions About Sandoz Group AG (SDZ:SW) Stock
Stock Target Advisor's fundamental analysis for Sandoz Group AG's stock is Slightly Bullish .
SDZ:SW stock's dividend yield is 1.12%.
Our analysis grades SDZ:SW stock's dividend yield at A+. This means that SDZ:SW stock's dividend yield is above 100% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the SW exchange.
Based on this SDZ:SW may be a good dividend stock for its sector.
Unfortunately we do not have enough data on SDZ:SW's stock to indicate what its average analyst target is.
SDZ:SW stock's Price/Earning ratio is 228.00.
Our analysis grades SDZ:SW stock's Price / Earning ratio at F. This means that SDZ:SW stock's Price/Earning ratio is above 67% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the SW exchange.
Based on this SDZ:SW may be a overvalued for its sector.
The last closing price of SDZ:SW's stock was CHF 37.14.
The most recent market capitalization for SDZ:SW is CHF 17.26B.
Unfortunately we do not have enough analyst data on SDZ:SW's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Sandoz Group AG's stock.
As per our most recent records Sandoz Group AG has 22,633 Employees.
Sandoz Group AG's registered address is Forum 1, Basel, Switzerland, 4056.
You can get more information about it from Sandoz Group AG's website at https://www.sandoz.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Sandoz Group AG (SDZ:SW) Stock
Stock Target Advisor's fundamental analysis for Sandoz Group AG's stock is Slightly Bullish .
SDZ:SW stock's dividend yield is 1.12%.
Our analysis grades SDZ:SW stock's dividend yield at A+. This means that SDZ:SW stock's dividend yield is above 100% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the SW exchange.
Based on this SDZ:SW may be a good dividend stock for its sector.
Unfortunately we do not have enough data on SDZ:SW's stock to indicate what its average analyst target is.
SDZ:SW stock's Price/Earning ratio is 228.00.
Our analysis grades SDZ:SW stock's Price / Earning ratio at F. This means that SDZ:SW stock's Price/Earning ratio is above 67% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the SW exchange.
Based on this SDZ:SW may be a overvalued for its sector.
The last closing price of SDZ:SW's stock was CHF 37.14.
The most recent market capitalization for SDZ:SW is CHF 17.26B.
Unfortunately we do not have enough analyst data on SDZ:SW's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Sandoz Group AG's stock.
As per our most recent records Sandoz Group AG has 22,633 Employees.
Sandoz Group AG's registered address is Forum 1, Basel, Switzerland, 4056.
You can get more information about it from Sandoz Group AG's website at https://www.sandoz.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SDZ:SW !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
